Liposomal amphotericin B for complicated visceral leishmaniasis (kala-azar) in eastern Sudan: how effective is treatment for this neglected disease?

Author:

Salih Niven A.1,van Griensven Johan2,Chappuis François34,Antierens Annick3,Mumina Ann1,Hammam Omar1,Boulle Philippa3,Alirol Emilie34,Alnour Mubarak5,Elhag Mousab S.6,Manzi Marcel7,Kizito Walter7,Zachariah Rony7

Affiliation:

1. Médecins Sans Frontières-Switzerland; North Sudan mission; Gedaref Sudan

2. Institute of Tropical Medicine; Antwerp Belgium

3. Médecins Sans Frontières-Switzerland - Medical Department; Geneva Switzerland

4. Geneva University Hospitals; Geneva Switzerland

5. Ministry of Health, Gedaref State; Gedaref Sudan

6. Federal Ministry of Health; Khartoum Sudan

7. Médecins Sans Frontières-Luxembourg; Luxembourg

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Parasitology

Reference22 articles.

1. Leishmaniasis worldwide and global estimates of its incidence;Alvar;PLoS One,2012

2. Liposomal amphotericin B as a treatment for human leishmaniasis;Balasegaram;Expert Opinion on Emerging Drugs,2012

3. Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries;Berman;Bulletin of the World Health Organization,1998

4. Liposomal amphotericin B for the treatment of visceral leishmaniasis;Bern;Clinical Infectious Diseases,2006

5. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?;Chappuis;Nature Reviews Microbiology,2007

Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Visceral Leishmaniasis in a Twin Pregnancy: A Case Report and Review of the Literature;Journal of Clinical Medicine;2024-04-20

2. Vaccine value profile for leishmaniasis;Vaccine;2023-11

3. Bioinformatics Perspective of Drug Repurposing;Current Bioinformatics;2023-10-10

4. Comment on “Dosing implications for liposomal amphotericin B in pregnancy”;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2023-09

5. The status of combination therapy for visceral leishmaniasis: an updated review;The Lancet Infectious Diseases;2023-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3